Prasada Shobha, Bhat Archana, Bhat Sevitha, Shenoy Mulki Shalini, Tulasidas Sanyuktha
Department of Microbiology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Manipal McGill Center for Infectious Diseases, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Infect Drug Resist. 2019 May 29;12:1439-1443. doi: 10.2147/IDR.S201849. eCollection 2019.
To assess the changing antibiotic sensitivity pattern in Uropathogenic over a period of time (2013-2017) with a special emphasis on ESBL-producing This retrospective study was carried out in the Department of Microbiology, Kasturba Medical College, Ambedkar Circle, Mangalore. A retrospective time bound analysis of 500 samples/year was performed. The urine samples received from the suspected cases of urinary tract infection (UTI) were processed. Wet mount examinations of urine samples were done. The urine culture was done by a semi-quantitative method on Mac Conkey's agar, Cysteine Lactose Electrolyte Deficient (CLED) medium, and UTI Chrome agar. Culture plates were incubated for 18-24 hours at 37°C. Urine samples with a colony count of ≥10 CFU/ml were considered significant. The uropathogens were identified by their biochemical reactions. The antibiotic susceptibility testing (AST) was carried out using a Vitek Compact 2 system and Modified Kirby Bauer disc diffusion method. Antibiotic resistance of Uropathogenic to cephalosporins increased from 51 to 58%, Cotrimoxazole: 52 to 59%, Piperacillin tazobactam 9.4 to 23%, Carbapenems 0 to 5.9%. Antibiotic resistance to netilmicin has reduced from 8 to 6.5%, and norfloxacin 59 to 48%. The rates of ESBL production have increased from 45.2 to 59.6% in the 5 years. The increasing antibiotic resistance trends in UTI patients indicate that it is vitally important to use them conservatively. Proper guidelines, management of antibiotic usage, and constant information to the clinicians regarding the sensitivity pattern can help to prevent drug resistance.
为评估一段时间内(2013 - 2017年)尿路致病性细菌抗生素敏感性模式的变化,特别关注产超广谱β-内酰胺酶(ESBL)的细菌。本回顾性研究在芒格洛尔安贝德卡尔圆环卡斯图尔巴医学院微生物学系开展。对每年500份样本进行回顾性限时分析。对疑似尿路感染(UTI)病例的尿液样本进行处理。进行尿液样本的湿片检查。通过半定量方法在麦康凯琼脂、半胱氨酸乳糖电解质缺乏(CLED)培养基和UTI铬琼脂上进行尿液培养。培养平板在37°C下孵育18 - 24小时。菌落计数≥10 CFU/ml的尿液样本被视为有意义。通过生化反应鉴定尿路致病菌。使用Vitek Compact 2系统和改良的 Kirby Bauer纸片扩散法进行抗生素敏感性试验(AST)。尿路致病性细菌对头孢菌素的耐药性从51%增加到58%,复方新诺明从52%增加到59%,哌拉西林他唑巴坦从9.4%增加到23%,碳青霉烯类从0增加到5.9%。对奈替米星的耐药性从8%降至6.5%,对诺氟沙星的耐药性从59%降至48%。5年中产ESBL的比率从45.2%增加到59.6%。UTI患者中抗生素耐药性增加的趋势表明谨慎使用抗生素至关重要。适当的指南、抗生素使用管理以及向临床医生持续提供关于敏感性模式的信息有助于预防耐药性。